Skip to main content

Pharmacy

By Jeff Lagasse | 11:26 am | December 07, 2022
The company believes the equivalent therapies will lower healthcare costs while providing more choice and flexibility.
By Jeff Lagasse | 03:08 pm | December 06, 2022
The end result will be a "diversified pharmacy solutions organization" serving commercial markets and government programs.
By Jeff Lagasse | 11:44 am | December 06, 2022
The AHA recommended that the DEA release proposed rules for telehealth special registration as soon as possible.
By Jeff Lagasse | 03:35 pm | November 09, 2022
The AG's office alleges the PBM was paid for drugs for workers' compensation claims that were in excess of what's allowed under state law.
By Jeff Lagasse | 12:39 pm | November 09, 2022
Substitution of costly generics with lesser-cost ones could generate great savings, Johns Hopkins says.
By Jeff Lagasse | 12:13 pm | November 02, 2022
The vaccine demonstrated efficacy of almost 82% against severe RSV in infants from birth through the first 90 days of life.
By Susan Morse | 12:04 pm | November 02, 2022
The payments will be made over 10-15 years, with neither company admitting wrongdoing.
By HIMSS TV | 06:00 am | October 26, 2022
<div style="position: relative; display: block; max-width: 100%;"> <div style="padding-top: 56.
By Jeff Lagasse | 12:03 pm | October 25, 2022
Merck joins drugmakers AstraZeneca, Novartis, Eli Lilly, Novo Nordisk and others singled out for potential fines.
By Jeff Lagasse | 03:45 pm | October 24, 2022
Orphan drugs are priced more than 30 times higher than non-orphan drugs, the UnitedHealth Group subsidiary says.